Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN12974924) titled 'The efficacy and safety of a high- concentration hybrid hyaluronic acid in patients with knee osteoarthritis: an open-label study' on Jan. 20.

Study Type: Interventional

Study Design: Prospective single-center open-label clinical study (Efficacy, Safety, Treatment)

Primary Sponsor: IBSA Farmaceutici (Italy)

Condition: Kellgren-Lawrence grade 2-3 knee Osteoarthrosis Musculoskeletal Diseases

Intervention: Single-dose (Population A) or repeated-dose (Population B) intra-articular injections of Sinovial(R) HL 90 (4.5%).

Population A: single injection of Sinovial(R) HL 90. The follow-up period lasted 6 months. P...